By Associate Professor John Zaunders

Preprints

Loprete J; Montemayor J; Richardson R; Rogers J; Tong W; Zaunders J; Carr A, 2024, Peanut oral immunotherapy plus omalizumab for 24 weeks safely induces tolerance at 48 weeks in allergic adults (The OPAL Study), http://dx.doi.org/10.22541/au.171724288.82777427/v1

Khoo WH; Jackson K; Phetsouphanh C; Zaunders J; Alquicira-Hernandez J; Yazar S; Ruiz-Diaz S; Singh M; Dhenni R; Kyaw W; Tea F; Merheb V; Lee F; Burrell R; Howard-Jones A; Koirala A; Zhou L; Yuksel A; Catchpoole D; Lai C; Vitagliano T; Rouet R; Christ D; Tang B; West N; George S; Gerrard J; Croucher P; Kelleher A; Goodnow C; Sprent J; Powell J; Brilot F; Nanan R; Hsu P; Deenick E; Britton P; Phan TG, 2022, Clonal dynamics of SARS-CoV-2-specific T cells in children and adults with COVID-19, http://dx.doi.org/10.1101/2022.01.30.478400

Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks M; Law H; Danwilai T; Starr M; Munier ML; Christ D; Singh M; Croucher P; Brilot-Turville F; Turville S; Phan TG; Dore G; Darley D; Cunningham P; Matthews G; Kelleher A; Zaunders J, 2022, High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells, http://dx.doi.org/10.1101/2022.07.22.22277947

Gao X; Shen Q; Roco J; Frith K; Munier ML; Nekrasov M; Dalton B; He J-S; Jaeger R; Cook M; Zaunders J; Cockburn I, 2022, ZEB2 regulates the development of CD11c+ atypical B cells, http://dx.doi.org/10.1101/2022.09.01.506173

Suzuki K; Zaunders J; Gates T; Levert A; Butterly S; Liu Z; Ishida T; Huang C-S; Palmer S; Rae C; Jugé L; Cysique L; Brew B, 2021, Elevation of cell-associated HIV-1 RNA transcripts in CSF CD4+ T cells, despite suppressive antiretroviral therapy, is linked to in vivo brain injury, http://dx.doi.org/10.1101/2021.12.22.21268288

Back to profile page